This Month
‘Three parent’ babies born after medical breakthrough
Monash University and other experts hope their breakthrough will help combat previously incurable genetic diseases.
June
IVF patients share horror stories amid Monash embryo bungle
The revelation of a second mix-up at a Monash IVF clinic this week has led to renewed calls for greater industry regulation.
Monash IVF bungle leaves booming sector under the spotlight
After two embryo transfers were botched, there are growing calls for nationally consistent laws to strengthen regulation of the sector.
‘No Plan B’ on AUKUS; Monash CEO quits; Wall Street bubble fears
Read everything that’s happened in the news so far today.
Monash IVF CEO resigns after second embryo mix-up
Chief executive Michael Knaap has resigned days after the embattled fertility company admitted to a second embryo error in just three months.
Monash IVF admits to second embryo transfer bungle this year
Shares in the fertility services group, the largest in the country, have fallen by half since the first incident was disclosed two months ago.
Monash IVF’s Richard Davis and injections where they shouldn’t be
The board of the ASX-listed fertility clinic disclosed a second embryo disaster on Tuesday.
Monash IVF shreds more than share price with second embryo bungle
The collapse in the company’s share price suggests investors think customers will abandon the fertility market leader, too. One way or another, this crisis is likely to lead to change.
Monash shares dive; Marines in LA; iPhone’s big update
Read everything that’s happened in the news so far today.
UNSW spin-off JumpStart Fertility lands US backer
JumpStart Fertility is seeking to boost embryo development and improve success rates by 60 per cent.
May
Monash IVF downgrades full-year profit outlook
Analysts blame Monash IVF’s profit downgrade on softer volumes industry-wide rather than an exodus of patients following its Brisbane embryo mix-up.
April
Australian IVF screening start-up pulls Nasdaq IPO, blames US tariffs
The company has developed a test to screen embryos for thousands of genetic diseases in the In Vitro Fertilisation process.
Monash IVF disaster shows board’s market insensitivity
Giving a client the wrong embryo and not realising until well after the child is born seems like it should be a big deal to the board.
March
BGH Capital in turnaround mode at Virtus Health; opportunistic funds lurk
Sources said BGH Capital has tipped $100 million in fresh equity into Virtus over the past year to reduce leverage and fund expansion.
February
Australia should punt on bold, unproven ideas: Shergold
The Australian Research Council chairman says this country needs to get behind young researchers whose work takes greater risks but offers larger rewards.
October 2024
The start-up revolutionising male fertility tests
A home testing kit for men helps avoid the inconvenience and embarrassment of trips to IVF clinics.
September 2024
Trump is a ‘deer in the headlights’ on one key issue
Heading into the campaign’s final stretch, Republicans careen between their base and swing voters on the powerful issue of reproductive rights.
August 2024
IVF breakthrough shows AI just as good as humans, and much faster
A world-first study led by Australian researchers found an AI-powered embryo selection tool led to a similar number of pregnancies as human embryologists.
April 2024
Companies picking up the bill for employees’ egg freezing and IVF
Google has joined the growing ranks of companies offering financial reimbursements to staff for fertility treatments.
March 2024
Aussie IVF guru plans Nasdaq listing
GenEmbryomics founder Nick Murphy invented a test to screen embryos for genetic disorders. He wants to go public in the US, where the company’s customers live.